Schamroth Pravda, N.; Golovchiner, G.; Goldenberg, G.; Plakht, Y.; Wiessman, M.; Tal, S.; Barsheshet, A.; Kadmon, E.; Erez, A.; Skalsky, K.;
et al. Albumin as a Prognostic Marker for Atrial Fibrillation Recurrence following Cryoballoon Ablation of Pulmonary Venous. J. Clin. Med. 2023, 12, 264.
https://doi.org/10.3390/jcm12010264
AMA Style
Schamroth Pravda N, Golovchiner G, Goldenberg G, Plakht Y, Wiessman M, Tal S, Barsheshet A, Kadmon E, Erez A, Skalsky K,
et al. Albumin as a Prognostic Marker for Atrial Fibrillation Recurrence following Cryoballoon Ablation of Pulmonary Venous. Journal of Clinical Medicine. 2023; 12(1):264.
https://doi.org/10.3390/jcm12010264
Chicago/Turabian Style
Schamroth Pravda, Nili, Gregory Golovchiner, Gustavo Goldenberg, Ygal Plakht, Maya Wiessman, Shir Tal, Alon Barsheshet, Ehud Kadmon, Aharon Erez, Keren Skalsky,
and et al. 2023. "Albumin as a Prognostic Marker for Atrial Fibrillation Recurrence following Cryoballoon Ablation of Pulmonary Venous" Journal of Clinical Medicine 12, no. 1: 264.
https://doi.org/10.3390/jcm12010264
APA Style
Schamroth Pravda, N., Golovchiner, G., Goldenberg, G., Plakht, Y., Wiessman, M., Tal, S., Barsheshet, A., Kadmon, E., Erez, A., Skalsky, K., Grinberg, T., Nardi Agmon, I., Aviv, Y., Kornowski, R., Shiyovich, A., & Hamdan, A.
(2023). Albumin as a Prognostic Marker for Atrial Fibrillation Recurrence following Cryoballoon Ablation of Pulmonary Venous. Journal of Clinical Medicine, 12(1), 264.
https://doi.org/10.3390/jcm12010264